Simon Gault’s Insurance Denial Sparks Debate on Health Coverage Value
Celebrity chef Simon Gault paid for skin cancer surgery out of his own pocket after Southern Cross Health Insurance declined to cover the specialized procedure.
Health insurance premiums have been soaring over the past couple of years, with the annual premium inflation rate reaching 19% in the year to the June quarter, according to Stats NZ’s Consumers Price Index. As costs accelerate, policyholders face mounting financial pressure to determine if maintaining coverage makes sense.
Gault stated that a mark on his cheek turned out to be cancerous, but when his surgical specialist recommended Mohs surgery rather than a standard excision to secure a higher chance of complete removal, Southern Cross declined the application under criteria updated in December 2025. Gault noted that the insurer offered to pay for a standard excision instead, but refused to cover that portion while he paid the difference.
Insurance specialists offer sharply contrasting projections on long-term self-funding versus ongoing premium payments. Jon-Paul Hale, founder of Willowgrove Consulting, calculated that the average person holding medical insurance from age 20 to 70 would spend approximately $230,000 on premiums, with the majority accrued during the second half of that timeline. Hale noted that while self-funding requires saving substantial sums over decades, an unexpected health event early in life can outpace accumulated savings, citing a recent client claim of $265,000 for early-stage breast cancer within a 12-month period.
Conversely, Hale suggested that as policyholders age, the math shifts. While he previously advised reassessing specialist and test cover at age 65, recent price increases have pulled that threshold back to age 55. For a couple at age 55, spending roughly $250 a month solely on specialist and tests cover amounts to funding a monthly follow-up appointment, leading him to suggest that policyholders not utilizing that volume of care might be better off redirecting premium payments into personal savings, provided they account for potential loss of access to diagnostic imaging such as MRIs and CT scans.
Tim Fairbrother, founder of Rival Wealth, emphasized that Gault was not denied overall coverage, but rather a specific surgical method that fell outside current funding criteria, comparing the restriction to non-Pharmac drug exclusions. Fairbrother stated that the primary value of insurance lies in shielding households from catastrophic medical expenses running into tens or hundreds of thousands of dollars, noting that many New Zealanders would struggle to absorb a major medical bill without coverage.
Industry representatives defend the pricing and structural changes. Savage explained that eligibility criteria for specific treatments like Mohs surgery are tied to clinical need and evolve alongside medical evidence, and advised members to consult insurers or financial advisers before altering or cancelling policies, warning that dropping coverage can permanently exclude pre-existing conditions if reinstated later.
Rising disputes accompany the financial strain. The Insurance and Financial Services Ombudsman managed 170 health insurance-related disputes in the year to June, marking a 91 percent increase compared to the previous year, according to the NZ Herald.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.